Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5588
-0.0154 (-2.68%)
At close: May 23, 2025, 4:00 PM
0.5600
+0.0012 (0.21%)
After-hours: May 23, 2025, 7:56 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $48.15 million as of May 23, 2025. Its market cap has decreased by -80.97% in one year.
Market Cap
48.15M
Enterprise Value
-64.30M
1-Year Change
-80.97%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $48.15M, a decrease of -95.42%. That is a compound annual growth rate of -54.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 48.15M | -43.94% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.06B |
| Johnson & Johnson | 367.19B |
| AbbVie | 322.44B |
| Novo Nordisk | 299.78B |
| UnitedHealth Group | 269.12B |
| Abbott Laboratories | 228.79B |
| Novartis AG | 219.95B |
| AstraZeneca | 215.99B |